Quarterly report pursuant to Section 13 or 15(d)

Accrued and Other Current Liabilities

Accrued and Other Current Liabilities

3 Months Ended

Mar. 31, 2023

5. Accrued and Other Current Liabilities

Accrued and other current liabilities consist of the following as of March 31, 2023 and December 31, 2022 (in thousands):


	March 31, 2023		December 31, 2022
Accrued research and development service fees	$	4,019	$	3,443
Accrued compensation costs		1,653		1,676
Accrued professional fees		1,382		970
Accrued insurance and facilities operation expenses		1,066		252
Other accrued expenses		30		157

Total accrued and other current liabilities	$	8,150	$	6,498

In February 2023, the Company entered into a financing agreement for $0.9 million for a portion of the Company’s annual directors and officers insurance premiums. The balance is due in monthly installments over eight months with an annual interest rate of 6.25%. The remaining balance was $0.8 million as of March 31, 2023 and was included in accrued and other current liabilities on the consolidated balance sheet.